Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 



